Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Clover Biopharmaceuticals, Ltd. See All Filings	D/A	2025-04-28 14:14:50 UTC
Amount To Be Raised $904,859 Associated Brokers / Dealers N/A CIK Number 0001856491 Filed Document 0001856491-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-04-28 14:14:50 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CHINA Revenue or Assets Decline to Disclose Type of Security Equity
Clover Biopharmaceuticals, Ltd. See All Filings	D	2024-04-11 21:52:35 UTC
Amount To Be Raised $320,713 Associated Brokers / Dealers N/A CIK Number 0001856491 Filed Document 0001856491-24-000005 Exclusions or Exemptions 506b Accepted Date 2024-04-11 21:52:35 UTC Type of Offering D Industry Biotechnology Principal Place of Business CHINA Revenue or Assets Decline to Disclose Type of Security Equity
Clover Biopharmaceuticals, Ltd. See All Filings	D/A	2023-05-09 06:01:55 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001856491 Filed Document 0001104659-23-057396 Exclusions or Exemptions 506b Accepted Date 2023-05-09 06:01:55 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CHINA Revenue or Assets Decline to Disclose Type of Security Equity
Clover Biopharmaceuticals, Ltd. See All Filings	D/A	2022-05-24 07:07:47 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001856491 Filed Document 0001104659-22-064094 Exclusions or Exemptions 506b Accepted Date 2022-05-24 07:07:47 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CHINA Revenue or Assets Decline to Disclose Type of Security Equity
Clover Biopharmaceuticals, Ltd. See All Filings	D	2021-04-28 14:28:25 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001856491 Filed Document 0001104659-21-056432 Exclusions or Exemptions 506b Accepted Date 2021-04-28 14:28:25 UTC Type of Offering D Industry Biotechnology Principal Place of Business CHINA Revenue or Assets Decline to Disclose Type of Security Equity